IGC Pharma Expands Phase 2 Trial of IGC-AD1 to Include the University of Puerto Rico - IGC Pharma, INC.

Press

Releases

August 2, 2023

IGC Pharma Expands Phase 2 Trial of IGC-AD1 to Include the University of Puerto Rico

Related Posts

IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Canadian Hamilton Health Sciences

March 20, 2025

IGC Pharma Expands CALMA Trial with Addition of BayCare Health System in Florida

March 17, 2025

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the “Reports Q3 results. We believe more positive clinical data in 2025 to be strong catalysts for stock. Raising P/T to $4.25”

March 12, 2025

CEO Update

Recap of AAIC24 Conference Participation and Poster Presentations

August 28, 2024

Desk of CEO Marijuana Reclass

July 25, 2024